Evaluating vonoprazan bismuth-containing triple therapy versus quadruple therapy for Helicobacter pylori

被引:0
|
作者
Tang, W-Z [1 ]
Li, J-Z [1 ]
Liu, T-H [1 ]
机构
[1] Chongqing Med Univ, Sch Basic Med Sci, Dept Bioinformat, Chongqing, Peoples R China
关键词
D O I
10.1111/jgh.16753
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days
    Ding, Yu-Ming
    Duan, Miao
    Han, Zhong-Xue
    Song, Xiao-Hui
    Zhang, Feng-Lan
    Wang, Zhi
    Ning, Zhang
    Zeng, Shu-yan
    Kong, Qing-Zhou
    Zhang, Wen-Lin
    Liu, Jing
    Wan, Meng
    Lin, Min-Juan
    Lin, Bo-Shen
    Nan, Xue-ping
    Wang, Hui
    Li, Yue-Yue
    Zuo, Xiu-Li
    Li, Yan-Qing
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (07) : 2540 - 2547
  • [32] Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for Helicobacter pylori infection
    Bang, Chang Seok
    Lim, Hyun
    Jeong, Hae Min
    Shin, Woon Geon
    Choi, Jae Ho
    Soh, Jae Seung
    Kang, Ho Suk
    Yang, Young Joo
    Hong, Ji Taek
    Shin, Suk Pyo
    Suk, Ki Tae
    Lee, Jae Jun
    Baik, Gwang Ho
    Kim, Dong Joon
    [J]. GUT MICROBES, 2020, 11 (05) : 1314 - 1323
  • [33] High-dose dual therapy versus bismuth-containing quadruple therapy for the eradication of Helicobacter pylori: A systematic review and meta-analysis
    Wang, Hui
    Kong, Qing Zhou
    Li, Yue Yue
    Yang, Xiao Yun
    Zuo, Xiu Li
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2024, 25 (03) : 163 - 175
  • [34] Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial
    Huang, Yu
    Lu, Hong
    [J]. JOURNAL OF GASTROENTEROLOGY, 2024, 59 (04) : 358 - 358
  • [35] Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial
    Yu Huang
    Hong Lu
    [J]. Journal of Gastroenterology, 2024, 59 : 358 - 358
  • [36] ERADICATION OF HELICOBACTER PYLORI WITH VONOPRAZAN-BISMUTH CONTAINING QUADRUPLE THERAPY IN CHINA: A COST-EFFECTIVENESS ANALYSIS
    Zhu, S.
    Li, Y.
    Liu, Y.
    Sheng, Y.
    Li, H.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S146 - S146
  • [37] Comparison of the efficacy of 10 day-triple therapy-based, bismuth-containing quadruple therapy including lansoprazole with esomeprazole for the first line therapy of Helicobacter pylori
    Moon, B. S.
    Lim, H.
    Lee, S.
    Lee, Y.
    [J]. HELICOBACTER, 2017, 22
  • [38] Meta-Analysis of Levofloxacin-Containing Triple Therapy vs. Bismuth-Containing Quadruple Therapy as Second-Line Treatment in the Eradication of Helicobacter pylori
    Marin, Alicia C.
    McNicholl, Adrian G.
    Gisbert, Javier P.
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S483 - S483
  • [39] Meta-Analysis of Levofloxacin-Containing Triple Therapy vs. Bismuth-Containing Quadruple Therapy as Second-Line Treatment in the Eradication of Helicobacter pylori
    Marin, Alicia C.
    McNicholl, Adrian G.
    Gisbert, Javier P.
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S880 - S880
  • [40] Rifabutin-Containing Triple Therapy Versus Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter, Randomized Controlled Trial
    Chen, Jinnan
    Guo, Yixian
    Huang, Yu
    Ding, Zhaohui
    Wang, Jing
    Liang, Xiao
    Xu, Ping
    Han, Yaohua
    Lu, Hong
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2023, 228 (05): : 511 - 518